Literature DB >> 9532469

The ocular manifestations of rheumatoid disease.

S L Harper1, C S Foster.   

Abstract

The inflammatory arthropathies that affect the eye most commonly are RA, JRA, and the seronegative spondyloarthropathies. These conditions not only cause devastating systemic findings but can be the source of damaging ocular disease. The inflammatory nature of these entities, with the accompanying liberation of mediators of inflammation, can result in a cycle of tissue destruction that culminates in blindness. The diseases reviewed can present first with systemic or ocular findings; thus, all physicians must be equipped with the appropriate knowledge to make accurate and timely diagnoses so that appropriate management strategies can be employed. The successful recognition and treatment of these conditions can prevent their associated systemic and ocular morbidity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9532469     DOI: 10.1097/00004397-199803810-00003

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  11 in total

1.  An assessment of ocular elasticity using real time ultrasound and ocular response analyzer in active or remission rheumatoid arthritis.

Authors:  Mehmet Erol Can; Özlem Unal; Meltem Ece Kars; Sukran Erten; Gamze Dereli Can; Necati Duru; Nurullah Cagil
Journal:  Int Ophthalmol       Date:  2018-12-03       Impact factor: 2.031

2.  Central corneal thickness and corneal curvature in patients with rheumatoid arthritis.

Authors:  Fatih Özcura; Serdar Aktaş; Yasemin Özkan; Mehmet Tetikoğlu; Hacı Murat Sağdik
Journal:  Int Ophthalmol       Date:  2016-05-09       Impact factor: 2.031

Review 3.  Inflammatory conditions of the eye associated with rheumatic diseases.

Authors:  N A Afshari; M A Afshari; C S Foster
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

4.  Successful treatment of severe nodular scleritis with adalimumab.

Authors:  Juan P Restrepo; María P Molina
Journal:  Clin Rheumatol       Date:  2010-02-14       Impact factor: 2.980

5.  Ocular surface and intraocular inflammation are related in SS-I and rheumatoid arthritis patients.

Authors:  Mauro Cellini; Piera Versura; Pietro Leonetti; Marilena Frigato; Elena Manfredini; Nazzarena Malavolta; Emilio C Campos
Journal:  Rheumatol Int       Date:  2007-02-13       Impact factor: 2.631

6.  Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.

Authors:  Sujit Itty; Jose S Pulido; Sophie J Bakri; Keith H Baratz; Eric L Matteson; David O Hodge
Journal:  Trans Am Ophthalmol Soc       Date:  2008

Review 7.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

8.  Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature.

Authors:  Rachel G Simpson; Majid Moshirfar; Jason N Edmonds; Steven M Christiansen; Nicholas Behunin
Journal:  Clin Ophthalmol       Date:  2012-11-05

9.  Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker.

Authors:  Fany Solange Usuba; Ana Cristina de Medeiros-Ribeiro; Priscila Novaes; Nadia Emi Aikawa; Karina Bonfiglioli; Ruth Miyuki Santo; Eloisa Bonfá; Milton Ruiz Alves
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

10.  Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Authors:  Pilar Uribe-Reina; Juliana Muñoz-Ortiz; Carlos Cifuentes-González; Juliana Reyes-Guanes; Juan Pablo Terreros-Dorado; William Zambrano-Romero; Carolina López-Rojas; Fabien Mantilla-Sylvain; Rubén Darío Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.